Refresh

Orchid Pharma Ltd. - Research Center

524372 ORCHPHARMA Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

665.90 556.97 450.70 505.45 583.65
Expenses

Material consumed

397.18 326.80 240.76 263.64 299.63

Manufacturing expenses

61.26 52.74 39.31 52.74 48.76

Personnel expenses

65.35 60.21 64.40 81.48 79.14

Selling expenses

0.04 0.04 0.02 0.02 0.37

Adminstrative expenses

58.45 59.93 48.31 151.84 168.43

Expenses capitalised

- - - - -

Cost of sales

582.28 499.72 392.81 549.71 596.34

Operating profit

83.62 57.26 57.89 -44.26 -12.69

Other recurring income

19.43 9.00 6.48 24.49 16.93

Adjusted PBDIT

103.05 66.26 64.36 -19.78 4.24

Financial expenses

32.23 87.02 51.34 4.16 0.30

Depreciation

54.79 32.01 108.90 125.90 129.92

Other write offs

- - - - -

Adjusted PBT

16.04 -52.77 -95.87 -149.84 -125.99

Tax charges

- - - - -

Adjusted PAT

- - - - -

Non recurring items

38.15 47.96 -21.28 88.56 24.94

Other non cash adjustments

- - - - -

Reported net profit

54.19 -4.81 -117.15 -61.28 -101.05

Earnigs before appropriation

-2,082.45 -2,138.10 -2,133.89 -2,014.85 -1,954.48

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

-2,082.45 -2,138.10 -2,133.89 -2,014.85 -1,954.48
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com